Protagonist Therapeutics

Home » Protagonist Therapeutics

Secondary

Protagonist Therapeutics

Protagonist is a clinical development-stage biopharmaceutical company that utilizes a proprietary technology platform to discover and develop novel peptide-based drugs to address significant unmet medical needs.

Symbol

PTGX

Last Closing Price
$19.81

Shares
2,000,000

Effective Date
October 12, 2017

Underwriters
Leerink Partners, Barclays, BMO Capital Markets, Stifel

To view the prospectus for Protagonist Therapeutics, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253